| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 03/03/2005 | WO2005019422A2 Silencing of tgf-beta receptor type ii expression by sirna |
| 03/03/2005 | WO2005019421A2 Crosslinking within coordination complexes |
| 03/03/2005 | WO2005019420A2 Chimeric receptors with disrupted dileucine motifs |
| 03/03/2005 | WO2005019419A2 Co-detection of single polypeptide and polynucleotide molecules |
| 03/03/2005 | WO2005019417A2 Bacterial strains, compositions including same and probiotic use thereof |
| 03/03/2005 | WO2005019415A2 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 03/03/2005 | WO2005019414A2 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 03/03/2005 | WO2005019413A2 A low maintenance detector for biological agents |
| 03/03/2005 | WO2005019412A2 Mucosal immunization to prevent prion infection |
| 03/03/2005 | WO2005019410A2 Rnai agents for anti-sars coronavirus therapy |
| 03/03/2005 | WO2005019409A2 Combinatorial protein library screening by periplasmic expression |
| 03/03/2005 | WO2005019408A2 Plants resistant to cytoplasm-feeding parasites |
| 03/03/2005 | WO2005007799A3 Methods for ex-vivo expanding stem/progenitor cells |
| 03/03/2005 | WO2005001037A3 Electrolyte membranes based on alkyloxysilane grafted thermoplastic polymers |
| 03/03/2005 | WO2004113493A3 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 03/03/2005 | WO2004092353A3 Surface receptor complexes as biomarkers |
| 03/03/2005 | WO2004092325A3 Screening methods using zebrafish to identify thrombotic and anti-thrombotic compounds and genes |
| 03/03/2005 | WO2004090104A3 Detecting gene expression in live cells using short-lived reporters with enzymatic amplification |
| 03/03/2005 | WO2004078925A8 Methods and compositions for treating and preventing neurodegenerative diseases |
| 03/03/2005 | WO2004072269A9 Bex4 nucleic acids, polypeptides, and method of using |
| 03/03/2005 | WO2004072265A3 Methods for monitoring drug activities in vivo |
| 03/03/2005 | WO2004069182A3 Active immunization to generate antibodies to soluble a-beta |
| 03/03/2005 | WO2004065583A3 Gene expression markers for breast cancer prognosis |
| 03/03/2005 | WO2002074911A3 Identification of gene expression alterations underlying the aging process in mammals |
| 03/03/2005 | US20050050101 Identification and use of informative sequences |
| 03/03/2005 | US20050049309 Regulation of HIF protein levels via deubiquitination pathway |
| 03/03/2005 | US20050049176 Treating a hypoproliferative cell disorder or disorder involving increased cell death in a patient by administering a therapeutically effective amount of an EphA2 antagonistic agent; treatment of Inflammatory Bowel Disease |
| 03/03/2005 | US20050048624 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 03/03/2005 | US20050048622 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders |
| 03/03/2005 | US20050048579 Using three dimensional structure of cellular adhesion molecule to drug design non-peptide modulator of cellular adhesion molecule activity; designing drugs for treatment of cell proliferative and autoimmune diseases |
| 03/03/2005 | US20050048556 Expression vector comprising nucleotide sequences coding polypeptides which confer herbicide resistance to plants; tissue engineering and biological pest comtrol |
| 03/03/2005 | US20050048535 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 03/03/2005 | US20050048530 Replicating nucleotide sequences in high hydrogen ion conentration environment via mixture comprising modified thermostable polymerase and amplification enhancing factors |
| 03/03/2005 | US20050048500 Soluble analyte detection and amplification |
| 03/03/2005 | US20050048470 Expression vector comprising nucleotide sequences coding recombinase inhibitor for use in treatment and prevention of viral infcetion and diseases |
| 03/03/2005 | US20050048460 Using abrutin to stabilze blood platelets and cell mixtures |
| 03/03/2005 | CA2536918A1 Serine protease inhibitors for treatment of bacterial infections |
| 03/03/2005 | CA2536654A1 Anti-cancer vaccines |
| 03/03/2005 | CA2535976A1 A novel gene and protein associated with angiogenesis and endothelial apoptosis |
| 03/03/2005 | CA2535969A1 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders |
| 03/03/2005 | CA2535951A1 Bacterial strains, compositions including same and probiotic use thereof |
| 03/03/2005 | CA2535516A1 Silencing of tgf-beta receptor type ii expression by sirna |
| 03/03/2005 | CA2535513A1 Crosslinking within coordination complexes |
| 03/03/2005 | CA2535132A1 Plants resistant to cytoplasm-feeding parasites |
| 03/03/2005 | CA2531400A1 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 03/03/2005 | CA2531146A1 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof |
| 03/03/2005 | CA2523658A1 Rnai agents for anti-sars coronavirus therapy |
| 03/02/2005 | EP1510580A2 Novel hepatitis C E1 and E2 truncated polypeptides and methods of obtaining the same |
| 03/02/2005 | EP1509203A2 Delivery of nucleic acid-like compounds |
| 03/02/2005 | CN1589330A Stem cells of the islets of langerhans and their use in treating diabetes |
| 03/02/2005 | CN1191364C Process for obtaining transgenic leguminous plants (leguminosae) containing exogeneous DNA |
| 03/01/2005 | US6861220 Genetic screening methods |
| 03/01/2005 | US6861056 Applying composition comprising interferon gamma antibodies topically to eye to treat hyperimmune reactions such as transplant rejection, uveitis, autoimmune diseases of eye |
| 02/24/2005 | WO2005017488A2 Method and system for identifying biological entities in biological and environmental samples |
| 02/24/2005 | WO2005017149A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | WO2005017128A2 Improved reagents for recombinogenic engineering and uses thereof |
| 02/24/2005 | WO2005017125A2 Method for isolation and replication of infectious human hepatitis-c virus |
| 02/24/2005 | WO2005017124A2 Peptide deformylase inhibitors |
| 02/24/2005 | WO2005017123A2 Mptens as modifiers of the pten pathway and methods of use |
| 02/24/2005 | WO2005017122A2 Biocompatibile linkers for surface plasmon resonance biosensors |
| 02/24/2005 | WO2005017120A2 Mracs as modifiers of the rac pathway and methods of use |
| 02/24/2005 | WO2005017117A2 Multipotent amniotic fetal stem cells (mafsc) and banking of same |
| 02/24/2005 | WO2005017116A2 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 02/24/2005 | WO2005017115A2 Cord blood-derived hematopoietic progenitor cells |
| 02/24/2005 | WO2005017114A2 Method of increasing metabolism and stress tolerance in a plant |
| 02/24/2005 | WO2005017113A2 Metalloproteinase gene polymorphism in copd |
| 02/24/2005 | WO2005017112A2 Methods of inhibiting cancer growth by binding to nuclear receptors |
| 02/24/2005 | WO2005017111A2 Methods and systems for identifying micro-rna targets and synthesizing novel micro-rnas and uses of the same |
| 02/24/2005 | WO2005017110A2 Engineered proteases for affinity purification and processing of fusion proteins |
| 02/24/2005 | WO2005017108A2 Soybean selection system based on aec-resistance |
| 02/24/2005 | WO2005017107A2 Specific binding agents to hepatocyte growth factor |
| 02/24/2005 | WO2005017106A2 Libraries of optimized cytochrome p450 enzymes and the optimized p450 enzymes |
| 02/24/2005 | WO2005017105A2 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450 |
| 02/24/2005 | WO2005017104A2 Cancer-linked gene as target for chemotherapy |
| 02/24/2005 | WO2005017103A2 Bacterial nitric oxide synthases and uses thereof |
| 02/24/2005 | WO2005017102A2 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 02/24/2005 | WO2005017101A2 Avian adenoassociated virus (aaav) and uses thereof |
| 02/24/2005 | WO2005017099A2 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 02/24/2005 | WO2005017096A2 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF |
| 02/24/2005 | WO2005017095A2 A stable liquid probiotic composition, preparation and applications thereof |
| 02/24/2005 | WO2005017094A2 N-acetyl compositions as adjunct therapy for treatment and prevention of cysteine/glutathione deficiency |
| 02/24/2005 | WO2005017093A2 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | WO2004104163A3 METHOD OF α-SELECTIVE GLYCOSYLATION |
| 02/24/2005 | WO2004101762A3 Detection and treatment of cancers of the colon |
| 02/24/2005 | WO2004099377A3 An autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells |
| 02/24/2005 | WO2004070000A3 Htlv-i-cell binding and inhibition |
| 02/24/2005 | WO2004049914A3 Methods for reacting an antigen masking compound with red blood cells with high efficiency |
| 02/24/2005 | US20050044586 Recombinant promoter drives tissue-specific expression of heterologous nucleic acid molecule in floral organ; improved fragrance and color |
| 02/24/2005 | US20050044579 Neurotransmitter signaling can regulate life span in C. elegans |
| 02/24/2005 | US20050043527 Delta-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts |
| 02/24/2005 | US20050043385 Hydroxyalkylindole derivatives as anticancer agent |
| 02/24/2005 | US20050043260 cardiomyocyte differentiation from a non-cardiomyocyte cell; cardiac specific polynucleotide selected from Nkx2.5, GATA4, MEF2C, Tbx5, CRIPTO, NODAL, and cardiac myosin heavy chain |
| 02/24/2005 | US20050043258 Contacting a salivary gland cell of a mammal with a protein selected from IFN-alpha, IL-10, sTNFR, TGF- beta , IL-4 and VIP, anti-TNF antibody, IL1-RA, other antibodies to proinflammatory cytokines, soluble gp39, soluble CD40, aquaporin-1 and aquaporin |
| 02/24/2005 | US20050042740 Using ligand conjugated matrix to isolate functional adenoassociated viral particles from solution |
| 02/24/2005 | US20050042723 Novel calcium channel |
| 02/24/2005 | US20050042721 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 02/24/2005 | US20050042706 Methods for the identification of inhibitors of porphobilinogen deaminase as antibiotics |
| 02/24/2005 | US20050042645 Expression vector comprising nucleotide sequences coding nitric oxide synthase for use in preparation of herbicides, antibiotics, nematicides, fungicides, insecticides and anticancer agents |
| 02/24/2005 | US20050042642 Using breast cancer gene expression as diagnostic indicator of cell proliferative disorders; antitumor agents |
| 02/24/2005 | US20050042641 In vivo high throughput selection of RNAi probes |